| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,732 |
25,575 |
$1.35M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,312 |
18,104 |
$1.11M |
| 99349 |
|
8,116 |
7,354 |
$341K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,621 |
3,351 |
$207K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
1,142 |
945 |
$135K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,019 |
1,883 |
$130K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
2,701 |
2,580 |
$127K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
919 |
811 |
$82K |
| 99348 |
|
2,911 |
1,889 |
$45K |
| 93000 |
|
5,574 |
5,100 |
$42K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
3,863 |
3,619 |
$32K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
2,035 |
1,914 |
$31K |
| 99350 |
Prolong home eval add 15m |
404 |
399 |
$26K |
| 94010 |
|
1,105 |
1,007 |
$23K |
| 71045 |
Radiologic examination, chest; single view |
1,408 |
1,240 |
$17K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
200 |
182 |
$11K |
| 93923 |
|
135 |
123 |
$10K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
788 |
713 |
$7K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
523 |
492 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
233 |
218 |
$5K |
| 99490 |
Ccm add 20min |
524 |
415 |
$5K |
| 99345 |
Prolong home eval add 15m |
54 |
54 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
263 |
241 |
$5K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
15 |
15 |
$4K |
| 72100 |
|
161 |
142 |
$4K |
| 99439 |
|
213 |
191 |
$4K |
| 81002 |
|
2,696 |
2,331 |
$3K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
111 |
104 |
$3K |
| 77080 |
|
48 |
45 |
$3K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
111 |
104 |
$2K |
| 82948 |
|
900 |
792 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
154 |
141 |
$1K |
| 92270 |
|
33 |
24 |
$1K |
| 99484 |
|
187 |
126 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
22 |
20 |
$1K |
| G2058 |
Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). |
179 |
111 |
$1K |
| 92546 |
|
58 |
32 |
$1K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
13 |
12 |
$1K |
| 81025 |
|
245 |
227 |
$1K |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
135 |
133 |
$1K |
| 94760 |
|
876 |
721 |
$924.16 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
26 |
12 |
$754.22 |
| 99406 |
|
370 |
332 |
$721.29 |
| 36415 |
Collection of venous blood by venipuncture |
260 |
251 |
$675.97 |
| 73560 |
|
14 |
12 |
$413.85 |
| 80050 |
General health panel |
40 |
38 |
$408.86 |
| G0180 |
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
39 |
39 |
$374.68 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
30 |
16 |
$276.68 |
| G0443 |
Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes |
53 |
45 |
$254.02 |
| 80061 |
Lipid panel |
47 |
45 |
$246.41 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
26 |
25 |
$241.65 |
| 99457 |
|
30 |
27 |
$238.51 |
| 92542 |
|
41 |
29 |
$200.02 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
31 |
30 |
$177.66 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
13 |
$170.44 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
25 |
24 |
$164.19 |
| 99458 |
|
17 |
14 |
$156.20 |
| 96127 |
|
43 |
42 |
$76.00 |
| 3044F |
|
1,115 |
1,041 |
$60.00 |
| 99497 |
|
177 |
162 |
$14.75 |
| 92547 |
|
57 |
32 |
$1.73 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
420 |
347 |
$0.00 |
| 1160F |
|
414 |
359 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
3,931 |
3,711 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
2,035 |
1,884 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
7,392 |
6,831 |
$0.00 |
| 1032F |
|
752 |
680 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,162 |
1,934 |
$0.00 |
| 1158F |
|
257 |
230 |
$0.00 |
| 3078F |
|
3,132 |
2,729 |
$0.00 |
| 1033F |
|
4,266 |
3,710 |
$0.00 |
| 1159F |
|
421 |
368 |
$0.00 |
| 3288F |
|
480 |
442 |
$0.00 |
| 3077F |
|
1,496 |
1,338 |
$0.00 |
| 1100F |
|
157 |
155 |
$0.00 |
| 3045F |
|
67 |
59 |
$0.00 |
| 4145F |
|
12 |
12 |
$0.00 |
| 99401 |
|
12 |
12 |
$0.00 |
| 1003F |
|
39 |
31 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
41 |
36 |
$0.00 |
| 3079F |
|
2,193 |
1,987 |
$0.00 |
| 3074F |
|
4,747 |
4,076 |
$0.00 |
| 3080F |
|
1,340 |
1,200 |
$0.00 |
| 1036F |
|
412 |
378 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
5,010 |
4,673 |
$0.00 |
| 1170F |
|
170 |
155 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
754 |
688 |
$0.00 |
| 0001F |
|
104 |
90 |
$0.00 |
| G9226 |
Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) |
71 |
67 |
$0.00 |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
44 |
41 |
$0.00 |
| 3008F |
|
518 |
449 |
$0.00 |
| 3075F |
|
421 |
385 |
$0.00 |
| 99000 |
|
188 |
178 |
$0.00 |
| 2001F |
|
567 |
492 |
$0.00 |
| 1101F |
|
132 |
120 |
$0.00 |
| 2010F |
|
218 |
208 |
$0.00 |
| 90686 |
|
27 |
13 |
$0.00 |
| 1111F |
|
101 |
93 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
49 |
46 |
$0.00 |
| 1125F |
|
132 |
123 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
60 |
52 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
21 |
16 |
$0.00 |
| 3017F |
|
29 |
22 |
$0.00 |